Latest Commercialization News

Symal Group has agreed to acquire an 80% stake in South Australian civil contractor Davison Earthmovers for $23.2 million, marking a strategic entry into a region with a booming infrastructure pipeline.

Electro Optic Systems has secured a US$21 million order for its R400 Remote Weapon System from a North American customer, boosting its contract backlog to over A$400 million and setting the stage for strong revenue growth in 2026 and 2027.

Alligator Energy has successfully completed the construction of its Samphire Uranium Project pilot plant, achieving practical completion safely, on schedule, and under budget. The company is now set to begin its Field Recovery Trial in early 2026, marking a pivotal step toward project development.

Amaero Ltd has secured a A$4.6 million order from Titomic under their exclusive five-year agreement, marking a significant step in supplying critical refractory and titanium powders for defense applications.

Nanoveu Limited has announced the tape-out of its next-generation ECS-DoT 16nm integrated circuit, alongside key collaborations with Arrow Electronics and Semtech, signaling a strong push into the ultra-low-power Edge AI market.

Altech Batteries has abruptly ended its partnership with AMPower, shifting focus to its own advanced battery technologies as part of a strategic reset by its new board.

Jumbo Interactive will subcontract with Brightstar Lottery PLC to deliver key components of Lotterywest’s new gaming and digital platform, marking a significant collaboration in the lottery technology space.

Genmin Limited has completed a A$25.7 million capital raise, wiping out its debt and positioning itself to accelerate development of its flagship Baniaka iron ore project in Gabon.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.

Dotz Nano Limited has raised approximately A$2 million through a private placement, reinforcing its position in the emerging carbon capture market with fresh capital and new investors.

Micro-X Limited has secured $6 million through a share placement to accelerate commercialisation of its innovative medical imaging technologies, with strategic partner Billion Prima increasing its stake to 8.5%. The capital raise supports key clinical trials and product development milestones.

Micro-X has raised $6.18 million through a placement that sees strategic partner Billion Prima increase its stake to 8.6%, funding key commercial and manufacturing scale-up initiatives in medical imaging.